日期 | 股東名稱 | 披露原因 | 買入/賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
09/10/2025 | 曲繼廣 | 1113(L) | +1,230,000(L) | HKD2.960(L) | 1,211,022,000(L) | 41.03 |
09/10/2025 | China Pharmaceutical Company Limited | 1101(L) | +1,230,000(L) | HKD2.960(L) | 886,304,000(L) | 30.03 |
08/10/2025 | 曲繼廣 | 1113(L) | +2,000,000(L) | HKD2.863(L) | 1,209,792,000(L) | 40.99 |
06/10/2025 | 曲繼廣 | 1113(L) | +3,000,000(L) | HKD2.900(L) | 1,207,792,000(L) | 40.92 |
26/09/2025 | UBS Group AG | 1314(L) | 3,863,000(L) | 188,256,135(L) | 6.44 | |
25/09/2025 | 曲繼廣 | 1113(L) | +1,200,000(L) | HKD2.966(L) | 1,204,792,000(L) | 40.82 |
25/09/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,200,000(L) | HKD2.966(L) | 885,074,000(L) | 29.99 |
24/09/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.912(L) | 883,874,000(L) | 29.95 |
24/09/2025 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.912(L) | 1,203,592,000(L) | 40.78 |
23/09/2025 | 曲繼廣 | 1113(L) | +5,000,000(L) | HKD2.935(L) | 1,202,592,000(L) | 40.75 |
22/09/2025 | UBS Group AG | 1313(L) | 6,164,658(L) | 186,795,222(L) | 6.38 | |
18/09/2025 | UBS Group AG | 1113(L) | +13,453,000(L) | 187,617,222(L) | 6.41 | |
12/09/2025 | 曲繼廣 | 1113(L) | +900,000(L) | HKD3.057(L) | 1,197,592,000(L) | 40.58 |
11/09/2025 | 曲繼廣 | 1113(L) | +6,000,000(L) | HKD3.024(L) | 1,196,692,000(L) | 40.55 |
10/09/2025 | 曲繼廣 | 1113(L) | +880,000(L) | HKD3.105(L) | 1,174,092,000(L) | 39.78 |
10/09/2025 | China Pharmaceutical Company Limited | 1710(L) | +880,000(L) | HKD3.105(L) | 882,874,000(L) | 29.91 |
09/09/2025 | 曲繼廣 | 1113(L) | +1,030,000(L) | HKD3.186(L) | 1,173,212,000(L) | 39.75 |
09/09/2025 | UBS Group AG | 1213(L) | -8,379,358(L) | 170,385,811(L) | 5.81 | |
09/09/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,030,000(L) | HKD3.186(L) | 881,994,000(L) | 29.88 |
08/09/2025 | China Pharmaceutical Company Limited | 1710(L) | +440,000(L) | HKD3.280(L) | 880,964,000(L) | 29.85 |
08/09/2025 | UBS Group AG | 1314(L) | 1,234,000(L) | 178,401,169(L) | 6.08 | |
08/09/2025 | 曲繼廣 | 1113(L) | +440,000(L) | HKD3.280(L) | 1,172,182,000(L) | 39.72 |
05/09/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,880,000(L) | HKD3.086(L) | 880,524,000(L) | 29.83 |
05/09/2025 | 曲繼廣 | 1113(L) | +1,880,000(L) | HKD3.086(L) | 1,171,742,000(L) | 39.70 |
04/09/2025 | China Pharmaceutical Company Limited | 1710(L) | +880,000(L) | HKD2.965(L) | 878,644,000(L) | 29.77 |
04/09/2025 | 曲繼廣 | 1113(L) | +880,000(L) | HKD2.965(L) | 1,169,862,000(L) | 39.64 |
29/08/2025 | UBS Group AG | 1313(L) | 3,329,200(L) | 182,912,269(L) | 6.23 | |
11/08/2025 | UBS Group AG | 1316(L) | 849,000(L) | 177,562,186(L) | 6.05 | |
05/08/2025 | UBS Group AG | 1314(L) | 526,969(L) | 177,086,343(L) | 6.03 | |
30/07/2025 | UBS Group AG | 1314(L) | 66,000(L) | 176,879,357(L) | 6.03 | |
22/07/2025 | UBS Group AG | 1314(L) | 862,000(L) | 177,102,634(L) | 6.04 | |
15/07/2025 | UBS Group AG | 1314(L) | 1,676,000(L) | 177,222,088(L) | 6.04 | |
14/07/2025 | UBS Group AG | 1305(L) | 520,000(L) | 182,068,088(L) | 6.20 | |
11/06/2025 | UBS Group AG | 1201(L) | -3,192,000(L) | HKD2.979(L) | 204,947,540(L) | 6.98 |
03/06/2025 | UBS Group AG | 1201(L) | -7,726,000(L) | HKD2.970(L) | 228,790,696(L) | 7.77 |
19/05/2025 | 曲繼廣 | 1113(L) | +500,000(L) | HKD2.930(L) | 1,168,982,000(L) | 39.61 |
19/05/2025 | China Pharmaceutical Company Limited | 1710(L) | +500,000(L) | HKD2.930(L) | 877,764,000(L) | 29.74 |
16/05/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,776,000(L) | HKD2.886(L) | 877,264,000(L) | 29.72 |
16/05/2025 | 曲繼廣 | 1113(L) | +1,776,000(L) | HKD2.886(L) | 1,168,482,000(L) | 39.59 |
29/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.955(L) | 875,488,000(L) | 29.64 |
1 2 3 4 |
備註: | (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。 |
(S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。 | |
(P) - 可供借出的股份 | |
即時報價更新時間為 10/10/2025 17:59 | |
港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |